Global OPO Infant Formula Market Research Report 2022

OPO is a structured triglyceride where palmitic acid bonded to the middle position (sn-2) of the glycerol backbone. Structured triglycerides are achieved through an enzymatic process using vegetable oils. The development of sn-2 Palmitate structured triglycerides enables mimicking both the composition as well as the structure of human milk fat. Vegetable oils that are commonly used as source for infant formula fat have the opposite structure where the palmitic is located mainly at sn-1 and sn-3 positions. Enzymatic process on vegetable oils enables changing the position of palmitic acid to the sn-2 position. Clinical studies in preterm and term infants, as well as preclinical animal model studies, show that enrichment of infant formula with sn-2 Palmitate results in increased fat absorption, reduced calcium soaps formation and stool hardness, increased calcium retention and larger skeletal mineral deposition.
Due to the COVID-19 pandemic, the global OPO Infant Formula market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe OPO Infant Formula market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe OPO Infant Formula landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Cow Milk Formula accounting for % of the OPO Infant Formula global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While 0 - 6 Month segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of OPO Infant Formula include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott and Brightdairy, etc. In terms of revenue, the global 3 largest players have a % market share of OPO Infant Formula in 2021.
This report focuses on OPO Infant Formula volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall OPO Infant Formula market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global OPO Infant Formula Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Cow Milk Formula
Goat Milk Formula
Segment by Application
0 - 6 Month
6 - 12 Month
12 - 36 Month
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
BiosTime
Nutriben
Ausnutria
HERDS
Milupa
Shanxi Yatai
Beingmate
Abbott
Brightdairy
Feihe
Wyeth Nutrition
Deloraine
Yili
Kabrita